Expo West reflections: post-recession buy-outs and GMP compliance

By Shane Starling

- Last updated on GMT

Related tags: Good manufacturing practice, President of the united states

Private equity firms came in droves to Expo West looking for post-recession bargains, with dietary supplements firm in their sights. A NutraIngredients-USA.com straw poll in the supplements aisles confirmed acquisition offers were as abundant as natural and organic product launches.

Shane Starling sat down with Frank Jaksch, the president and CEO of California-based third party testing company, Chromadex, to assess the ramifications of this kind of consolidation.

When Good Manufacturing Practices (GMP) – which smaller players are due to comply with this June – are thrown into the equation, Jaksch expects a more concentrated market with less products, and less complicated products.

Jaksch also offers tips to meet GMP demands and reduce compliance costs.

Related topics: GMPs, QA & QC, Suppliers

Related news

Show more

Follow us


View more